AzTrials
AzTrials

Otitis MediaNCT00365092

Middle Ear Disease Before Age 3, Treatment With Ear Tubes, and Literacy and Attentional Abilities at Ages 9 to 11

A study testing Insertion of tympanostomy tubes in people with Otitis Media and Middle Ear Effusion, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Middle-ear disease (infection and fluid) is the most common illness in young children after the common cold. Because hearing loss accompanies middle-ear disease, and because early life is a period of rapid development, concern has existed that sustained periods of middle-ear disease might cause lasting impairments of… Read more about this study

Who is it for?
Ages 0 years to 61 daysHealthy volunteers can take part
Conditions the study is for
Otitis Media, Middle Ear Effusion
What is being tested?
Insertion of tympanostomy tubes
Type of treatment
Surgery or procedure
How many people
400 participants
Where
1 siteUnited States
Study dates
Apr 2002to Mar 2005
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 years to 61 days
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Healthy, less than 62 days of age at enrollment

Who cannot join

  • birth weight less than 5 lb (2268 g)
  • small for gestational age
  • history of neonatal asphyxia or other serious illness
  • major congenital abnormality or chronic illness
  • multiple birth
  • sibling enrolled in the study
Show all 11Show fewer
  • in foster care or adopted before enrollment
  • mother dead, seriously ill, a known drug or alcohol abuser before enrollment
  • mother judged by study personnel to be too limited socially or intellectually to give informed consent or adhere to the study protocol
  • mother less than 18 years of age
  • English not the only household language

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, 15213

Other trials in United States

About this study

Official title: Early Otitis and Literacy and Attention at 9 to 11 Years

Middle-ear disease (infection and fluid) is the most common illness in young children after the common cold. Because hearing loss accompanies middle-ear disease, and because early life is a period of rapid development, concern has existed that sustained periods of middle-ear disease might cause lasting impairments of learning, speech development, language development, or behavior and social adjustment. Earlier phases of this research found that the insertion of ear tubes in children younger than 3 years of age with persistent middle-ear disease did not affect their development at 3, 4, or 6 years of age. This study examines the children's literacy, attention, and related abilities at 9 to 11 years of age.

Read the detailed description

Concern has long existed that persistent otitis media in young children, because of the associated conductive hearing loss, can result in lasting impairments of the children's development. Accordingly, myringotomy with insertion of tympanostomy tubes has often been undertaken in such children in order to promptly restore hearing to normal. However, evidence concerning developmental effects of persistent early-life otitis media has been inconclusive, and evidence that tube insertion in affected children influences their development favorably has been lacking. From a previous study we reported that among a cohort of children younger than three years of age with persistent effusion, prompt as compared with delayed insertion of tympanostomy tubes did not result in improved developmental outcomes in the children at three, four, and six years of age. The purpose of the present study was to assess developmental outcomes in the same children at nine to eleven years of age.

Beginning in 1991, we enrolled 6350 healthy infants less than 62 days of age and evaluated them at least monthly until they reached three years of age. We randomly assigned 429 of the children who developed persistent middle-ear effusion before reaching that age to have tympanostomy tubes inserted either promptly or up to nine months later if effusion persisted. At three, four, and six years of age we systematically assessed the children's cognitive, language, speech, and psychosocial development. In the present study, using a standardized battery of assessments, we evaluated literacy, attentional abilities, social skills, and academic achievement in 391 of these children at nine to eleven years of age.

Being tested
Insertion of tympanostomy tubes
Keywords
Insertion of tympanostomy tubes, Otitis media with effusion, Child development, Literacy, Attention, Middle-ear effusion, Educational status, Behavior, Social behavior, Achievement
Medical subject headings
Otitis Media, Otitis Media with Effusion, Literacy, Behavior, Social Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Insertion of tympanostomy tubesProcedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. All measures at 9 to 11 years of age:

  2. Woodcock Reading Mastery Tests-Revised-Normative Update

  3. Number of words in a grade-level passage read correctly in one minute

  4. Dictation Samples subtest of the Woodcock-Johnson III Tests of Achievement, Standard Battery

  5. Writing Samples subtests of the Woodcock-Johnson III Tests of Achievement, Standard Battery

  6. Elision and Rapid Letter Naming subtests of the Comprehensive Test of Phonological Processing

  7. Children's version of the Hearing in Noise Test

  8. Disruptive Behavior Disorders Rating Scale

  9. Child Behavior Checklist, parent report

  10. Child Behavior Checklist, teacher report

  11. Impairment Rating Scales, parent report

  12. Impairment Rating Scales, teacher report

  13. Computerized visual continuous performance test

  14. Computerized auditory continuous performance test

  15. Wechsler Abbreviated Scale of Intelligence

  16. Computational subtest of the Woodcock-Johnson III Tests of Achievement, Standard Battery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2006 (estimated)
  2. Study startApr 2002
  3. Study completionMar 2005

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Enrolment
400 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00365092
Sponsor's protocol ID
R01HD042080
Status last verified
Aug 2006
First submitted
15 Aug 2006
Last updated
17 Aug 2006
Results posted
No

Publications

  • Paradise JL, Campbell TF, Dollaghan CA, Feldman HM, Bernard BS, Colborn DK, Rockette HE, Janosky JE, Pitcairn DL, Kurs-Lasky M, Sabo DL, Smith CG. Developmental outcomes after early or delayed insertion of tympanostomy tubes. N Engl J Med. 2005 Aug 11;353(6):576-86. doi: 10.1056/NEJMoa050406.

    PubMed 16093466
  • Paradise JL, Dollaghan CA, Campbell TF, Feldman HM, Bernard BS, Colborn DK, Rockette HE, Janosky JE, Pitcairn DL, Kurs-Lasky M, Sabo DL, Smith CG. Otitis media and tympanostomy tube insertion during the first three years of life: developmental outcomes at the age of four years. Pediatrics. 2003 Aug;112(2):265-77. doi: 10.1542/peds.112.2.265.

    PubMed 12897272
  • Paradise JL, Feldman HM, Campbell TF, Dollaghan CA, Colborn DK, Bernard BS, Rockette HE, Janosky JE, Pitcairn DL, Sabo DL, Kurs-Lasky M, Smith CG. Early versus delayed insertion of tympanostomy tubes for persistent otitis media: developmental outcomes at the age of three years in relation to prerandomization illness patterns and hearing levels. Pediatr Infect Dis J. 2003 Apr;22(4):309-14. doi: 10.1097/01.inf.0000059764.77704.55.

    PubMed 12690269
  • Paradise JL, Feldman HM, Campbell TF, Dollaghan CA, Colborn DK, Bernard BS, Rockette HE, Janosky JE, Pitcairn DL, Sabo DL, Kurs-Lasky M, Smith CG. Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. N Engl J Med. 2001 Apr 19;344(16):1179-87. doi: 10.1056/NEJM200104193441601.

    PubMed 11309632
  • MacKeith S, Mulvaney CA, Galbraith K, Webster KE, Connolly R, Paing A, Marom T, Daniel M, Venekamp RP, Rovers MM, Schilder AG. Ventilation tubes (grommets) for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD015215. doi: 10.1002/14651858.CD015215.pub2.

    PubMed 37965944
  • Paradise JL, Feldman HM, Campbell TF, Dollaghan CA, Rockette HE, Pitcairn DL, Smith CG, Colborn DK, Bernard BS, Kurs-Lasky M, Janosky JE, Sabo DL, O'Connor RE, Pelham WE Jr. Tympanostomy tubes and developmental outcomes at 9 to 11 years of age. N Engl J Med. 2007 Jan 18;356(3):248-61. doi: 10.1056/NEJMoa062980.

    PubMed 17229952

Questions about this trial

What is this clinical trial studying?

A study testing Insertion of tympanostomy tubes in people with Otitis Media and Middle Ear Effusion, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Aug 2006. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

All measures at 9 to 11 years of age:. The study lists 16 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00365092, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2006.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in